HALEOSLABS vs NGLFINE: Stock Comparison

HALEOS LABS vs NGL FINE CHEMUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

NGL FINE CHEM is the larger company by market capitalisation. HALEOS LABS shows a lower P/E and a higher dividend yield, while NGL FINE CHEM shows a higher ROE, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

HALEOSLABS leads 4; NGLFINE leads 9 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

HALEOSLABSNGLFINE

Valuation lens

What price are you paying?

Market CapContext only
₹443 Cr
₹1,804 Cr
P/E RatioHALEOSLABS has the lower reading
0x
30.41x
P/B RatioHALEOSLABS has the lower reading
0x
5.28x
EPSNGLFINE has the higher reading
₹10.71
₹29.78
Book ValueContext only
₹759.29
₹532.9
Dividend YieldHALEOSLABS has the higher reading
0.1%
0.07%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
NGLFINE is the larger company
₹1,804 Cr vs ₹443 Cr
P/E Ratio
HALEOSLABS has a lower P/E
0x vs 30.41x
P/B Ratio
HALEOSLABS has a lower P/B
0x vs 5.28x
EPS
NGLFINE has higher earnings per share
₹29.78 vs ₹10.71
Dividend Yield
HALEOSLABS has a higher dividend yield
0.1% vs 0.07%
Revenue Growth (TTM YoY)
NGLFINE has faster revenue growth
57.2% vs 0%
EPS Growth (TTM YoY)
NGLFINE has faster EPS growth
1,539.8% vs 0%
Qtr Sales Growth
NGLFINE has stronger quarterly sales growth
1.79% vs -7.01%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricHALEOSLABSNGLFINE
SectorHealthcare
IndustryPharmaceuticals

Price

MetricHALEOSLABSNGLFINE
Live Price₹1,451.3₹2,907.5
Day Change-2.08%-1.13%
Volume5,1647,107
52-Week High₹1,774₹3,602
52-Week Low₹1,181₹1,271
Distance from 52W High-18.19%-19.28%

Valuation

MetricHALEOSLABSNGLFINE
Market Cap₹443 Cr₹1,804 Cr
P/E Ratio0x30.41x
P/B Ratio0x5.28x
EPS₹10.71₹29.78
Book Value₹759.29₹532.9
Dividend Yield0.1%0.07%

Growth

MetricHALEOSLABSNGLFINE
Revenue Growth (TTM YoY)0%57.2%
EPS Growth (TTM YoY)0%1,539.8%
Qtr Sales Growth-7.01%1.79%
Qtr Profit Growth75.94%11.83%

Profitability & Leverage

MetricHALEOSLABSNGLFINE
ROE8.28%13.01%
ROCE7.15%10.54%
Net Margin5.33%9.59%
Operating Margin10.37%12.08%
Debt to Equity0.43x0.34x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricHALEOSLABSNGLFINE
Promoter Holding72.11%72.49% 0.25 pp
FII Holding0%0.05% 0.02 pp
DII Holding0.31% 0.01 pp0.02% 0.02 pp
Public Holding27.58% 0.02 pp27.43% 0.19 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: HALEOS LABS and NGL FINE CHEM.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.